BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 34491673)

  • 1. Dermoscopic features of clofazimine-induced pigmentation in a borderline tuberculoid leprosy plaque.
    Behera B; Palit A; Sethy M; Nayak AK; Dash S; Ayyanar P
    Indian J Dermatol Venereol Leprol; 2021; 88(1):85-87. PubMed ID: 34491673
    [No Abstract]   [Full Text] [Related]  

  • 2. Borderline tuberculoid leprosy with type 1/reversal reaction.
    Khardenavis S; Deshpande A
    BMJ Case Rep; 2014 Jan; 2014():. PubMed ID: 24481019
    [No Abstract]   [Full Text] [Related]  

  • 3. Clofazimine-induced cutaneous hyperpigmentation as a source of stigma in the treatment of leprosy: A cross-sectional study.
    Nogueira AS; Garcia MAC; Silva MBD; Costa PFD; Frade MAC; Salgado CG; Barreto JG
    Trop Med Int Health; 2024 Apr; 29(4):327-333. PubMed ID: 38348585
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Primary hyperpigmented palmar lesion: a rare presentation of borderline tuberculoid leprosy.
    Grover S; Singh G; Dash K
    Indian J Lepr; 1997; 69(2):191-3. PubMed ID: 9290973
    [No Abstract]   [Full Text] [Related]  

  • 5. Daily multidrug therapy for leprosy; results of a fourteen-year experience.
    de Carsalade GY; Wallach D; Spindler E; Pennec J; Cottenot F; Flageul B
    Int J Lepr Other Mycobact Dis; 1997 Mar; 65(1):37-44. PubMed ID: 9207752
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clofazimine-induced skin pigmentation.
    Karnan A; Ledwani A
    Pan Afr Med J; 2024; 47():86. PubMed ID: 38737223
    [No Abstract]   [Full Text] [Related]  

  • 7. Minocycline is effective and cosmetically preferred to clofazimine by leprosy patients in New York.
    Levis WR; Spencer TI; Ladizinski B
    J Drugs Dermatol; 2010 Aug; 9(8):906. PubMed ID: 20684139
    [No Abstract]   [Full Text] [Related]  

  • 8. Brazilian clinical trial of uniform multidrug therapy for leprosy patients: the correlation between clinical disease types and adverse effects.
    Gonçalves Hde S; Pontes MA; Bührer-Sékula S; Cruz R; Almeida PC; Moraes ME; Penna GO
    Mem Inst Oswaldo Cruz; 2012 Dec; 107 Suppl 1():74-8. PubMed ID: 23283457
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Generalized annular borderline tuberculoid leprosy and update in management of Hansen's disease.
    Young RJ; Gilson RT; Elston DM
    Cutis; 2000 Apr; 65(4):203-6. PubMed ID: 10795079
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Image Gallery: Clofazimine-induced hyperpigmentation of leprosy plaques.
    Bishnoi A; Chatterjee D; Narang T; Dogra S
    Br J Dermatol; 2019 Oct; 181(4):e88. PubMed ID: 31281972
    [No Abstract]   [Full Text] [Related]  

  • 11. Chemotherapy trial in paucibacillary leprosy using clofazimine.
    Katoch K; Natarajan M; Katoch VM; Singh HB; Bhatia AS
    Indian J Lepr; 1999; 71(3):311-24. PubMed ID: 10626237
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sparing of tuberculoid leprosy patch in a patient with dapsone hypersensitivity syndrome.
    Ng PP; Goh CL
    J Am Acad Dermatol; 1998 Oct; 39(4 Pt 1):646-8. PubMed ID: 9777777
    [No Abstract]   [Full Text] [Related]  

  • 13. Fixed drug eruption due to rifampin.
    John SS
    Lepr Rev; 1998 Dec; 69(4):397-9. PubMed ID: 9927813
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multiple superficial sporotrichoid nerve abscesses with a hyperpigmented lesion in a tuberculoid leprosy patient: a rare and unusual presentation.
    Ghorpade A
    J Eur Acad Dermatol Venereol; 2006 Mar; 20(3):357-8. PubMed ID: 16503914
    [No Abstract]   [Full Text] [Related]  

  • 15. "Flu" syndrome on monthly rifampin dose; first case reported from Yemen.
    al-Samie AR; al-Qubati Y
    Int J Lepr Other Mycobact Dis; 1995 Dec; 63(4):574-6. PubMed ID: 8642225
    [No Abstract]   [Full Text] [Related]  

  • 16. Dapsone syndrome: an incomplete form.
    Jaswal R; Thami GP; Kanwar AJ
    Indian J Lepr; 1998; 70(2):229-30. PubMed ID: 9724867
    [No Abstract]   [Full Text] [Related]  

  • 17. Leprosy - an overview of clinical features, diagnosis, and treatment.
    Fischer M
    J Dtsch Dermatol Ges; 2017 Aug; 15(8):801-827. PubMed ID: 28763601
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Problems of multidrug therapy.
    Ramu G
    Indian J Lepr; 1991; 63(3-4):435-45. PubMed ID: 1804896
    [No Abstract]   [Full Text] [Related]  

  • 19. Leprosy in a preschool child--a case report.
    Arora SK
    J Indian Med Assoc; 2007 Mar; 105(3):140. PubMed ID: 17824468
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clofazimine-induced enteropathy in a patient of leprosy.
    Singh H; Azad K; Kaur K
    Indian J Pharmacol; 2013; 45(2):197-8. PubMed ID: 23716903
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.